Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with doce65

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with doce16

Views

Views
December 20252
January 20263
February 20260
March 20261
April 20267
May 20263
June 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Argentina1
Germany1
Algeria1
United Kingdom1
Greece1
Morocco1
Tunisia1
Turkey1
South Africa1
 

Top cities views

Views
Athens1
Bursa1
Córdoba1
Las Vegas1
Los Angeles1
Mission Viejo1
Sindelfingen1
Sétif1
Tunis1
Washington1